UCSF brain tumor vaccine trial shows promising results
... Our goal is to change the management of recurrent glioma from a life threatening disease, in which survival rates are typically 25 to 26 weeks, into a chronic disease with extended survival and improved quality of life for patients, Parsa said. Although our survival data are encouraging, a larger phase 2 s...Cancer drug can extend survival in patients with deadly brain tumors
.... Life expectancy after diagnosis of a stage IV glioma -- the most aggressive kind of the cancer -- is eight to 15 months, Vredenburgh said. Individuals diagnosed with a stage III glioma, which is slightly less aggressive, survive 16 to 24 months on average. When the tumor returns after initial treatment...Researchers identify genes that allow brain cancer-causing stem cells to resist treatment
... before. Results of studies on three established glioma cell lines and tumor tissue removed from five patients at Cedars-Sinai appear in the Dec. 2 issue of the journal Molecular Cancer. The researchers describe genes and mechanisms that give cancer stem cells their chemoresistant properties. They also al...Cancer immunoresistance linked to loss of tumor suppressor gene
... how specific mutations associated with high grade glioma correlate with immunoresistance. Malignant glioma is among the deadliest types of brain cancer for which there currently is no effective treatment. ...Vaccine for brain tumors shows promising results
...e cells. The most common site of involvement of a glioma is the brain. Malignant glioma is currently a fatal disease. The trial results are being presented at the Immunotherapy Task Force...Combined therapies may boost immune response and long-term protection against brain tumors
...endritic cells to recognize antigens, such as live glioma cells, that otherwise escape surveillance without ... after rechallenge, the implantation of additional glioma cells, and remained tumor-free at the end of the study. "Dendritic cells and interleukin-23 appear ...New hope in cancer vaccines emerges as novel therapies are developed and tested
...st one type of protein that studs the outside of a glioma tumor. This protein, epidermal growth factor variant III (EGFRvIII), is found on 30 percent to 50 percent of brain tumors, as well as on some breast and non-small-cell lung cancers, but not on normal tissue. Heimberger believes EGFRvIII drives glioma...Synthetic version of scorpion venom delivers radioactive iodine to malignant brain tumors
...the Giant Yellow Israeli scorpion. TM-601 binds to glioma cells and has an unusual ability to pass through t...ly as a carrier to transport radioactive iodine to glioma cells, although there are data to suggest that it may also slow down the growth of tumor cells. If s...Radioactive scorpion venom for fighting cancer
...ters the bloodstream, the compound attaches to the glioma cells, then the I-131 releases radiation that kills the cell. This compound has enabled an experimental treatment for high-grade gliomas, found in 17,000 people in the US every year and usually causing death in the first year of diagnosis. Patient...New compound unusually potent at blocking brain cancer growth
...liferation in studies of mice with grafts of human glioma cells. Gliomas are the most common form of brain c...e with the human tumors, the scientists found. The glioma research is being published online May 15 by the journal Cancer Cell. A description of the strategy ...M. D. Anderson: Setting the benchmark in brain tumor treatment
...an amazing amount about all the different pathways glioma cells use," says neurosurgeon Frederick Lang, M.D....er any evidence of the EGFRvIII protein on the new glioma - an indication that the vaccine worked but that the tumor morphed to use a different pathway to gro...Study finds novel vaccine curbs brain tumor growth, increases survival
...st one type of protein that studs the outside of a glioma tumor. This protein, epidermal growth factor variant III (EGFRvIII), is found on 30 percent to 50 percent of brain tumors, as well as on some breast and non-small-cell lung cancers, but not on normal tissue. Heimberger believes EGFRvIII drives glioma...Gliadel Wafer demonstrates long-term survival benefit for patients with high-grade malignant glioma
...patients with newly-diagnosed high-grade malignant glioma as an adjunct to surgery and radiation. Gliadel W...liadel Wafer in patients with high grade malignant glioma was associated with a 27% reduction in risk of death over the study period (P=0.018, log-rank statis...Marrow-derived stem cells deliver new cytokine to kill brain tumor cells, offer protection
...system cells have the ability to target and track glioma cells in the brain, even as they migrate. The rese...gulate immune responses to track down and destroy glioma cells. In 2002, the scientists reported that they had produced central nervous system cells from ste...Ginkgo biloba extract: More than just for memory?
...nd selected the aggressive breast cancer and brain glioma to study in mice. The researchers pretreated the a... of the breast tumors by more than 80 percent, but glioma tumors did not respond as strongly, and the benefit was maintained for only 50 days despite continuo...Infections could contribute to adult brain tumours
...een 1983 and 2001. They found clusters of cases of glioma tumours, which make up about half of all brain tumours, at different time intervals in different geographical locations. This 'space-time clustering' of cases is a pattern typical of diseases caused by infections, adding weight to the theory that...Mobile phone use not linked to increased risk of glioma brain tumours
...e of tumour. There was no relationship for risk of glioma and time since first use of a mobile phone, lifeti...eal effect. This finding may be due to people with glioma brain tumours linking mobile phone use to the side of the tumour and therefore over reporting the us...Variant in gene associated with telomeres predicts longer survival of deadly brain tumor
...atients with a cancer that is both the most common glioma and the one offering the poorest hope of survival. "It is a real advance because we have never seen any genotype that can stratify glioblastoma multiforme patients into different treatment outcome groups like this," says Bondy. "Now we need to verify...